GLP-1 / GIP / glucagon triple receptor agonist
Retatrutide
LY3437943
Investigational
Retatrutide is an investigational triple GIP / GLP-1 / glucagon receptor agonist under clinical development for obesity and metabolic disease. Investigational; not approved for marketing. Supported through CDMO development and active-ingredient supply.
Specification
| CAS number | 2381089-83-2 |
| Purity | ≥ 98% |
| Appearance | White to off-white powder |
| Storage | -20 °C ± 5 °C |
| Solubility | Water / DMSO |
Supplied for pharmaceutical manufacturing and R&D by licensed and qualified entities. Not for human use as supplied; availability is subject to regulatory approval in the buyer's jurisdiction.